ParenteralTopicalDosed ingredientTherapeutic flag Cosmetic cross-reference

Lactic Acid

CAS 50-21-5

Lactic Acid (CAS 50-21-5) is a Phase 4 pharmaceutical compound with 3 bioactivity targets and 3 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
3
SOURCE DrugCentral
Adverse signals
3
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Lactic Acid
CAS Number
50-21-5
UNII
3B8D35Y7S4
InChIKey
JVTAAEKCZFNVCJ-UHFFFAOYSA-N
ChEMBL ID
CHEMBL1200559
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
Synonyms and normalized names
LACTIC ACID, DL-
dosed ingredientnatural productparenteraltherapeutic flagtopical
SOURCE EMBL-EBI ChEMBL B25820EEF0F0

Clinical Development Phase

Highest clinical development phase rendered from the matched compound identifier rows.

Phase 4 (Approved)
Approved or marketed human pharmaceutical use is represented in the source phase field.
ChEMBL CHEMBL1200559 | Small molecule
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

This substance also has a cosmetic safety profile →
SOURCE EMBL-EBI ChEMBL 3 bioactivity rows

Bioactivity & Target Interactions

Target-level activity records with assay counts, activity type, and measured value where present.

TargetActivity ValueAssaysOrganism
- AC50 37646 nM 2 -
- IC50 25265 nM 2 -
- Potency 25.1 nM 1 -
SOURCE DrugCentral 3 associations

Adverse Event Associations

DrugCentral / FAERS disproportionality signal rows matched to this compound.

Reaction PTDrug AE LLRMedDRA
Product dose omission issue 41 21.947 10084406
Diarrhoea 80 18.283 10012735
Asthenia 53 17.039 10003549

Association rows are source-linked signal records, not incidence rates or clinical causality claims.

SOURCE NLM RxNorm 6 name rows

Drug Names / RxNorm

Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.

NameRxCUI TypeSource
Lactic Acid 28393 SU MTHSPL
LACTIC ACID 28393 SU MTHSPL
lactic acid 28393 SU MTHSPL
LACTIC ACID, DL- 1314409 SU MTHSPL
Lactic Acid, DL- 1314409 SU MTHSPL
lactic acid 28393 PIN RXNORM
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Lactic Acid used for in pharmaceutical contexts?

Lactic Acid (CAS 50-21-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Lactic Acid?

Lactic Acid has 3 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Product dose omission issue, Diarrhoea, Asthenia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Lactic Acid also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Lactic Acid with EU status "restricted".

What clinical phase is Lactic Acid in?

Lactic Acid is rendered with ChEMBL max phase 4 (approved).